Exploratory Study of Plaque Regression

Clinical trial NCT01515241 · COMPLETED

Trial details

NCT number: NCT01515241
Sponsor: Cerenis Therapeutics, SA
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Heterozygous Familial Hypercholesterolemia

Start date: 2012-01-01
Primary completion: 2012-04-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.